Rapidexon 2 mg/ml solution for injection

Χώρα: Ιρλανδία

Γλώσσα: Αγγλικά

Πηγή: HPRA (Health Products Regulatory Authority)

Δραστική ουσία:

Dexamethasone sodium phosphate

Διαθέσιμο από:

Eurovet Animal Health B.V.

Φαρμακολογική κατηγορία (ATC):

QH02AB02

INN (Διεθνής Όνομα):

Dexamethasone sodium phosphate

Δοσολογία:

2 milligram(s)/millilitre

Φαρμακοτεχνική μορφή:

Solution for injection

Τρόπος διάθεσης:

POM: Prescription Only Medicine as defined in relevant national legislation

Θεραπευτική ομάδα:

Cats, Cattle, Dogs, Horses, Pigs

Θεραπευτική περιοχή:

dexamethasone

Θεραπευτικές ενδείξεις:

Corticosteroid

Καθεστώς αδειοδότησης:

Authorised

Ημερομηνία της άδειας:

2008-04-04

Αρχείο Π.Χ.Π.

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Rapidexon 2 mg/ml solution for injection.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each millilitre contains:
ACTIVE SUBSTANCE:
Dexamethasone (as Dexamethasone Sodium Phosphate) 2.0 mg
EXCIPIENT:
Benzyl alcohol (E1519), 15.0 mg
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
A clear colourless solution practically free from particles.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horses, cattle, pigs, cats and dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In horses, cattle, pigs, dogs and cats:
Treatment of inflammatory or allergic conditions.
In cattle:
Treatment of primary ketosis (acetonaemia).
Induction of parturition
In horses:
Treatment of arthritis, bursitis or tenosynovitis.
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_3_
_0_
_/_
_0_
_1_
_/_
_2_
_0_
_1_
_4_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_6_
_4_
_3_
_7_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.3 CONTRAINDICATIONS
Except in emergency situations, do not use in animals suffering from
diabetes mellitus, renal insufficiency, cardiac
insufficiency, hyperadrenocorticism, or osteoporosis.
Do not use in viral infections during the viraemic stage or in cases
of systemic mycotic infections.
Do not use in animals suffering from gastrointestinal or corneal
ulcers, or demodicosis.
Do not administer intra-articularly where there is evidence of
fractures, bacterial joint infections and aseptic bone
necrosis.
Do not